mTOR, translational control and human disease
Top Cited Papers
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 16 (1) , 29-37
- https://doi.org/10.1016/j.semcdb.2004.11.005
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of TuberinJournal of Biological Chemistry, 2003
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature Cell Biology, 2003
- Rheb is an essential regulator of S6K in controlling cell growth in DrosophilaNature Cell Biology, 2003
- Two Motifs in the Translational Repressor PHAS-I Required for Efficient Phosphorylation by Mammalian Target of Rapamycin and for Recognition by RaptorJournal of Biological Chemistry, 2003
- Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in MiceCirculation, 2003
- TSC1–TSC2: a complex tale of PKB-mediated S6K regulationNature Cell Biology, 2002
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- Farnesyltransferase InhibitorsDrugs, 2001
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989